Paediatric Diseases Working Party (PDWP)
Type d'étude:
Numéro de l'étude:
8417024
Type de traitement à base de cellules souches:
Allogeneic
Maladies:
Acute Myeloid Leukaemia (AML)
Titre court:
Objectif principal:
To describe the clinical characteristics and outcomes (OS, DFS, NRM, relapse incidence) of pediatric patients with AML presenting with EMD and identify prognostic factors associated with improved outcome.
Principaux critères d'inclusion:
All patients ≤18 years of age who are affected by extramedullary disease associated with AML any time prior to transplantation with or without bone marrow involvement and who underwent an allo-HCT between 2008 and 2017.
Pays:
Investigateur principal:
Kanchan Rao
Coordinateur EBMT de l'étude:
Arnaud Dalissier